verapamil has been researched along with dexmedetomidine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Honkavaara, JM; Raekallio, MR; Vainio, OM | 1 |
1 review(s) available for verapamil and dexmedetomidine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for verapamil and dexmedetomidine
| Article | Year |
|---|---|
The effects of L-659,066, a peripheral α2-adrenoceptor antagonist, and verapamil on the cardiovascular influences of dexmedetomidine in conscious sheep.
Topics: Adrenergic alpha-2 Receptor Antagonists; Animals; Blood Pressure; Calcium Channel Blockers; Cardiac Output; Cross-Over Studies; Dexmedetomidine; Female; Heart Rate; Hypnotics and Sedatives; Quinolizines; Sheep; Vascular Resistance; Verapamil | 2010 |
1 other study(ies) available for verapamil and dexmedetomidine
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |